COMPARISON OF TOTAL MEDICAL COST AVOIDANCE WITH THE USAGE OF NEW ORAL ANTICOAGULANTS INSTEAD OF WARFARIN AMONG ATRIAL FIBRILLATION PATIENTS, BASED ON THE ARISTOTLE, RE-LY AND ROCKET-AF TRIALS Article

Full Text via DOI: 10.1016/S0735-1097(12)60600-7 Web of Science: 000302326700601

Cited authors

  • Deitelzweig, Steven; Amin, Alpesh; Jing, Yonghua; Makenbaeva, Dinara; Makenbaeva, Dinara; Wiederkehr, Daniel; Lin, Jay; Graham, John

Publication date

  • 2012

International Standard Serial Number (ISSN)

  • 0735-1097

Start page

  • E599

End page

  • E599

Volume

  • 59

Issue

  • 13